_{147. Simons DG: Triggerpunkte und Myogelose [Trigger points and myogelosis]. Manuelle Medizin 35(6): 190–294, 1997.}

_{148. Simons DG: Myofascial trigger points: the critical experiment. J Musculoske Pain 5(4):113–118, 1997.}

_{149. Simons DG, Dexter JR: Comparison of local twitch responses elicited by palpation and needling of myofascial trigger points. J Musculoske Pain 3(1):49–61, 1995.}

_{150. Simons DG, Hong CZ: Comment to Dr. Baldry’s dry needling technique. J Musculoske Pain 3(4):81–85, 1995.}

_{151. Simons DG, Hong CZ, Simons LS: Nature of myofascial trigger points, active loci [Abstract]. J Musculoske Pain 3(Suppl 1):62, 1995.}

_{152. Simons DG, Mense S: Understanding and measurement of muscle tone related to clinical muscle pain. Pain 75:1—17, 1998.}

_{153. Simons DG, Stolov WC: Microscopic features and transient contraction of palpable bands in canine muscle. Am J Phys Med Rehabil 55:65–88, 1976.}

_{154. Singh P, Maibach HI: Iontophoresis in drug delivery: basic principles and applications. Crit Rev Ther Drug Carrier Sys 11(2–3):161–213, 1994.}

_{155. Sola AE, Kuitert JH: Myofascial trigger point pain in the neck and shoulder girdle. Northwest Med 54:980–984, 1955.}

_{156. Stern S, Keren A: Extreme sinus bradycardia following routine venipuncture. JAMA 239:403–404, 1978.}

_{157. Stembach RA: Pain Patients. Academic Press, N. Y., 1974 (pp. 5-11).}

_{158. Tavernor D: Alleviation of postherpetic neuralgia. Lancet 2:671–673, 1960.}

_{159. Telling WH: The clinical importance of fibrositis in general practice. Br Med J 1:689–692, 1935.}

_{160. Tizes R: Cardiac arrest following routine venipuncture. JAMA 236: 1846–1847, 1976.}

_{161. Travell J: Rapid relief of acute «stiff neck» by ethyl chloride spray. J Am Med Worn Assoc 4:89–95, 1949.}

_{162. Travell J: Basis for the multiple uses of local block of somatic trigger areas (procaine infiltration and ethyl chloride spray). Miss Valley Med J 71:13–22, 1949.}

_{163. Travell J: Early relief of chest pain by ethyl chloride spray in acute coronary thrombosis. Case Report. Circulation 3:120–124, 1951.}

_{164. Travell J: Pain mechanisms in connective tissue. In: Connective Tissues, Transactions of the Second Conference, 1951. Edited by Ragan C. Josiah Macy, Jr. Foundation, New York, 1952 (pp. 90, 92–94, 105, 119, 121).}

_{165. Travell J: Ethyl chlorides spray for painful muscle spasm. Arch Phys Med Rehabil 33:291–298, 1952.}

_{166. Travell J: Referred pain from skeletal muscle: the pectoralis major syndrome of breast pain and soreness and the sternomastoid syndrome of headache and dizziness. NY State J Med 55:331–339, 1955 (pp. 332, 333).}

_{167. Travell J: Factors affecting pain of injection. JAMA 158:368–371, 1955.}

_{168. Travell J: Temporomandibular joint pain referred from muscles of the head and neck. J Prosthet Dent 10:745–763, 1960.}

_{169. Travell J: Use and abuse of the muscles in housework. J Am Worn Med Assoc 18:159–162, 1963.}

_{170. Travell J: Office Hours: Day and Night. The World Publishing Company, New York, 1968 (pp. 260, 262, 269, 270, 272, 273, 276, 283)}

_{171. Travell J: Myofascial trigger points: clinical view. In: Advances in Pain Research and Therapy Vol 1. Edited by Bonica JJ, Albe-Fessard D, Raven Press, New York, 1976 (pp. 919–926).}

_{172. Travell J: Identification of myofascial trigger point syndromes: a case of atypical facial neuralgia. Arch Phys Med Rehabil 62:100–106, 1981.}

_{173. Travell JG: Chronic myofascial pain syndromes: mysteries of the history. Chapter 6. In: Advances in Pain Research and Therapy, Vol 17. Edited by Fricton JR, Awad E. Raven Press, Ltd., New York, 1990 (pp. 129–137).}

_{174. Travell J, Koprowska I, Hirsch BB, et al.: Effect of ethyl chloride spray on thermal bums. J Pharmacol Exp Ther 101:36, 1951.}

_{175. Travell J, Rinzler SH: Influence of ethyl chloride spray on deep pain and ischemic contraction of muscle. Fed Proc 8:339, 1949.}

_{176. Travell J, Rinzler SH: The myofascial genesis of pain. Postgrad Med 11:425–434, 1952.}

_{177. Vandam LD: Local anesthetics, 1. N Engl J Med 263:748–750, 1960.}

_{178. Vecchiet L, Giamberardino MA, Dragani L, et al.: Latent myofascial trigger points: changes in muscular and subcutaneous pain thresholds at trigger point and target level. J Man Med 5:151–154, 1990.}

_{179. Vecchiet L, Giamberardino MA, de Bigontina P, et al.: Comparative sensory evaluation of parietal tissues in painful and nonpainful areas in fibromyalgia and myofascial pain syndrome, Chapter 13. In: Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, Vol. 2. Edited by Gebhart GF, Hammond DL, Jensen TS. IASP Press, Seattle, 1994, pp. 177–249.}

_{180. Vogler P, Kraus H: Periostbehandlung, Kolonbehandlung: Zwei reflextherapeutische Methoden. George Thieme, Leipzig, 1975 (pp. 52–69).}

_{181. Voss DE, Ionta MK, Myers BJ: Proprioceptive Neuromuscular Facilitation. Ed. 3. Harper & Row, Philadelphia, 1985.}

_{182. Voss H: Tabelle der Muskelwichte des Marines, berechnet und zusammengestellt nach der Untersuchungen von W. Thiele (1884). AnatAnz 103:356–360, 1956.}

_{183. Walpin LA: Bedroom posture: the critical role of a unique pillow in relieving upper spine and shoulder girdle pain. Arch Phys Med Rehabil 58:507, 1977.}

_{184. Walsh EG: Muscles, Masses & Motion. The Physiology of Normality, Hypotonicity, Spasticity & Rigidity. MacKeith Press, Distributed by Cambridge University Press, 1992.}

_{185. Weber EF: Ober die Langenverhaltnisse der Fleischfasem der Muskeln in Allgemeinen. Berichte ober die Verhandlungen der Koniglich Sachsischen Gesellschaft der Wissenschaften zu Leipzig 3:63–86, 1851.}

_{186. Weeks VD, Travell J: Postural vertigo due to trigger areas in the sternocleidomastoid muscle. J Pediatr 47:315–327, 1955.}

_{187. Weeks VD, Travell J: How to give painless injections. In A. M. A. Scientific Exhibits 1957. Grune & Stratton, New York, 1957 (pp. 318–322).}

_{188. Whiteside J: Personal communication, 1995.}

_{189. Willis WD Jr, Grossman RG: Medical Neurobiology. С. V. Mosby, St Louis, 1973 (p. 103).}

_{190. Wilson TS: Manipulative treatment of subacute and chronic fibrositis. Br Med J 1:298–302, 1936.}

_{191. Wu CM, Chen HH, Hong CZ: Inactivation of myofascial trigger points associated with lumbar radiculopathy: surgery versus physical therapy [Abstract). Arch Phys Med Rehabil 78:1040–1041, 1997.}

_{192. Yagiela JA, Benoit PW, Buoncristiani RD, et al.: Comparison of myotoxic effects of lidocaine with epinephrine in rats and humans. Anesth Analg 60:471–480, 1981.}

_{193. Yue SK: Initial experience in the use of boulinum toxin A for the treatment of myofascial related muscle dysfunctions [Abstract]. J Musculoske Pain 3(Suppl 1):22, 1995.}

_{194. Zohn DA, Mennell JM: Musculoskeletal Pain: Diagnosis and Physical Treatment. Little, Brown and Company, Boston, 1976 (pp. 126–129, 190–193).}

_Suppliers

_{Cervipillo, TRU-EZE Mfg. Co., 27 635 Diaz, Temecula, CA 92 390}

_{Dramanine, Searle Pharmaceuticals, Inc., Box 5110, Chicago, IL 60 680}

_{Fluori-Methane and ethyl chloride spray, Gebauer Chemical Co., 94 100 St. Catherine Ave., Cleveland, OH 44 104}

_{Hydrocollator Steam Pack, Chattanooga Corporation, 101 Memorial Drive, Chattanooga, TN 37 405}